z-logo
open-access-imgOpen Access
A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement
Author(s) -
Adriana G. Quiroz-Reyes,
Carlos A. González-Villarreal,
Herminia Guadalupe Martı́nez-Rodrı́guez,
Salvador SaidFernández,
Mario C. SalinasCarmona,
Alberto Yairh LimonFlores,
Adolfo SotoDomínguez,
Gerardo R. Padilla-Rivas,
Roberto MontesdeOcaLuna,
José Francisco Islas,
Elsa N. Garza-Treviño
Publication year - 2022
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2022.12722
Subject(s) - mesenchymal stem cell , cancer research , homing (biology) , lymphoma , bone marrow , medicine , oncogene , interferon , immunology , cancer , biology , cell cycle , pathology , ecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom